IO360° Summit Illuminates a Decade of Immunotherapy Breakthroughs, Charting a Future of Transformative Cancer Care
admin The annual IO360° Summit, held in February in Boston, Massachusetts, served as a crucial nexus...
admin
Resilience in Pediatric Oncology and the Clinical Challenges of Recurrent Neuroblastoma as Exemplified by the Case of Two-Year-Old Lily
The medical journey of two-year-old Lily, a child twice diagnosed with neuroblastoma, serves as a...
Advancing Pediatric Neuro-Oncology: New Clinical Trial Offers Hope for Children with Diffuse Midline Glioma
The landscape of pediatric neuro-oncology is witnessing a significant shift as a groundbreaking clinical trial...
Kathryn Taylor PhD Receives CureSearch Young Investigator Award to Pioneer Neuromodulatory Treatments for Pediatric Brain Cancer
Memorial Sloan Kettering Cancer Center researcher Kathryn Taylor, PhD, has been named the latest recipient...
Immunotherapy Revolutionizes Kidney Cancer Treatment, Offering Renewed Hope and Extended Survival.
A kidney cancer diagnosis, historically a harbinger of profound uncertainty and fear, is increasingly met...
BioNTech Founders Ugur Sahin and Özlem Türeci to Depart, Launching New mRNA Discovery Venture
Ugur Sahin and Özlem Türeci, the visionary co-founders who meticulously steered BioNTech from a nascent...
Building the Data-First Future of Immunotherapy
For over 70 years, the Cancer Research Institute (CRI) has stood at the vanguard of...
Biopharma Sector Buzzes with Strategic Approvals, Key Partnerships, and Market Reactions Across Global Health Landscapes
The biopharmaceutical industry is currently a hotbed of activity, marked by significant regulatory milestones, innovative...
Roche’s Amylin-Targeting Obesity Drug Petrelintide Underperforms in Phase 2, Raising Questions on Market Competitiveness
Basel, Switzerland – Hopes for Roche’s amylin-targeting obesity drug, petrelintide, have been tempered following the...
Servier to Acquire Day One Biopharmaceuticals in Multibillion-Dollar Deal to Bolster Rare Oncology Portfolio
French pharmaceutical giant Servier has reached a definitive agreement to acquire Day One Biopharmaceuticals, a...
